Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Iperionx Limited ( (AU:IPX) ) has provided an announcement.
IperionX Limited has notified the market of the issuance of new unquoted equity securities under its employee incentive scheme, including 59,000 performance rights expiring on 31 December 2025, 5,000 performance rights expiring on 31 December 2026, and 235,000 options expiring on 1 April 2027 with an exercise price of A$10.00. The securities are subject to transfer restrictions and will not be quoted on the ASX until those restrictions lapse, highlighting the company’s continued use of equity-based incentives to align staff interests with shareholders and potentially expanding its fully diluted capital base over time.
The most recent analyst rating on (AU:IPX) stock is a Buy with a A$9.90 price target. To see the full list of analyst forecasts on Iperionx Limited stock, see the AU:IPX Stock Forecast page.
More about Iperionx Limited
IperionX Limited is an Australia-listed company (ASX: IPX) that issues equity and performance-based securities, including options and performance rights, as part of its capital management and employee incentive programs.
Average Trading Volume: 1,548,919
Technical Sentiment Signal: Hold
Current Market Cap: A$1.69B
For a thorough assessment of IPX stock, go to TipRanks’ Stock Analysis page.